OncoPSM: an interactive tool for cost-effectiveness analysis using partitioned survival models in oncology trial

OncoPSM: an interactive tool for cost-effectiveness analysis using partitioned survival models in oncology trial

IntroductionCost-effectiveness analysis (CEA) serves as a critical tool to evaluate the economic sustainability of new treatments. However, many CEA tools are not specifically tailored to address the intricate cost composition resulting from the complex treatment regimens in oncology trials.MethodsW...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xulong Qiu, Jidi Chen, Muting Wang, Kaixin Zheng, Ruixiong Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-08-01
Series:	Frontiers in Pharmacology
Subjects:	cost-effectiveness analysis incremental cost-effectiveness ratio partitioned survival model oncology lung cancer
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1554405/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Optimal control and cost-effectiveness analysis of Q-fever transmission dynamics in livestock and humans
by: Nkuba Nyerere, et al.
Published: (2025-09-01)

Cost-utility analysis of omalizumab for the treatment of chronic spontaneous urticaria in China
by: Yueyang Huang, et al.
Published: (2025-07-01)

Cost-effectiveness analysis of penpulimab combined with paclitaxel and carboplatin as first-line treatment for advanced squamous non-small cell lung cancer
by: Xiaoyan You, et al.
Published: (2025-03-01)

Cost-effectiveness study of the MitraClip system for mitral regurgitation treatment in inoperable patients
by: E. G. Fedina, et al.
Published: (2021-09-01)

Towards a more comprehensive approach for a total economic assessment of vaccines?: 1. The building blocks for a health economic assessment of vaccination
by: Baudouin Standaert, et al.
Published: (2017-01-01)

Economic challenges of oncological diseases’ pharmacotherapy
by: E. A. Ushkalova, et al.
Published: (2020-04-01)

Clinical and economic studies on pharmacotherapy of malignant neoplasms: the modeling approach
by: A. G. Tolkushin, et al.
Published: (2019-01-01)

Cost effectiveness of mono, dual, and triple therapy of antihypertensive drugs: a retrospective cohort study
by: Abdullah, et al.
Published: (2025-08-01)

Time-Driven Activity-Based Costing (TDABC) applied in a chemotherapy department of a public reference oncology hospital
by: Amanda Oliveira Serra-Campos, et al.
Published: (2025-08-01)

Cost-effectiveness of pertussis booster vaccination of 6-year-old children
by: A. V. Rudakova, et al.
Published: (2025-03-01)

Cost effectiveness analysis of universal varicella vaccination in the Russian Federation
by: A. V. Rudakova, et al.
Published: (2021-10-01)

Value of Vaccinations: A Fundamental Public Health Priority to Be Fully Evaluated
by: Sara Boccalini
Published: (2025-04-01)

ON SEQUENCES OF ELEMENTARY TRANSFORMATIONS IN THE INTEGER PARTITIONS LATTICE
by: Vitaly A. Baransky, et al.
Published: (2023-12-01)

ENTERPRISE INNOVATIVE MODERNIZATION PROBLEMS AND CONDITIONS
by: N. P. Arzamasova, et al.
Published: (2016-12-01)

THE PARTITION DIMENSION OF CYCLE BOOKS GRAPH B_(m,n) WITH A COMMON PATH P_2
by: Jaya Santoso, et al.
Published: (2025-04-01)

Pharmacoeconomic analysis in various nosologies
by: A. A. Svistunov, et al.
Published: (2016-06-01)

PHARMACO-ECONOMIC COMPARISON OF ENOXAPARIN AND UNFRACTIONATED HEPARIN IN ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION
by: A. V. Syrov, et al.
Published: (2010-04-01)

Analysis of the efficiency and effectiveness of technology transformation through the introduction of ADC in the Emergency Department: a Taiwanese case study
by: Valerio Brescia, et al.
Published: (2025-07-01)

Cost-effectiveness of omalizumab in real world uncontrolled allergic asthma patients
by: A. Arrobas, et al.
Published: (2021-03-01)

VALUE OF THERAPEUTIC EQUIVALENCE IN SUBSTITUTION OF ORIGINAL DRUG WITH GENERIC BY EXAMPLE OF FOSINIPRIL
by: N. P. Kutishenko, et al.
Published: (2016-01-01)

Cost-effectiveness of new oral anticoagulants in the treatment and secondary prevention of venous thromboembolism
by: A. V. Rudakova
Published: (2015-11-01)

Cost Effectiveness of Contracting Out Vaccination Services in Two Districts of Sindh, Pakistan
by: Shiraz Shaikh, et al.
Published: (2025-08-01)

Сost-effectiveness of pentavalent rotavirus vaccination in the Russian Federation
by: A. V. Rudakova, et al.
Published: (2023-01-01)

Approaches for Health Technology Assessment in Europe: Situational Analysis
by: Slaveyko Djambazov, et al.
Published: (2016-12-01)

Bedrock Controls on Water and Energy Partitioning
by: Robert S. Ehlert, et al.
Published: (2024-08-01)

Cost-effectiveness analysis of the oncology patient navigation program at a referral cancer center for colorectal tumor treatment
by: Juliana Ribeiro Silva, et al.
Published: (2023-04-01)

PHARMACOECONOMIC EVALUATION OF INFLUENZA AND PNEUMOCOCCAL VACCINATION IN EMPLOYEES OF THE JOINT STOCK COMPANY "RUSSIAN RAILWAYS" (JSCO "RZD") ON INVESTMENT FOR THE EMPLOYER
by: D. A. Zhukov
Published: (2016-02-01)

Calculating Value in Hand and Wrist Care: A Systematic Review on the Current Literature
by: Zachary Chen, BS, et al.
Published: (2025-09-01)

Cost-effectiveness analysis of radiofrequency renal denervation for uncontrolled hypertension in Spain
by: Oriol Rodríguez-Leor, et al.
Published: (2024-11-01)

Determining optimal strategies for primary prevention of cardiovascular disease: systematic review of cost-effectiveness analyses in the United Kingdom
by: Hema Mistry, et al.
Published: (2022-12-01)

Cost-Consequences of Cladribine Tablets for the Treatment of Highly Active Relapsing–Remitting Multiple Sclerosis in Italy
by: Barbara Polistena, et al.
Published: (2025-06-01)

Malignant Futility in the Intensive Care Unit
by: Alev Öztaş, et al.
Published: (2024-12-01)

Clinical and cost-effectiveness of ACE inhibitors in patients with arterial hypertension and coronary heart disease
by: O. Yu. Korennova, et al.
Published: (2008-08-01)

Cost-Effectiveness of Itopride Hydrochloride for the Treatment of Functional Dyspepsia in Vietnam
by: Hansoo Kim, et al.
Published: (2025-01-01)

INFLUENZA VACCINATION OF CHILDREN OF PRESCHOOL AGE IN THE RUSSIAN FEDERATION: COST-EFFECTIVENESS OF QUADRIVALENT VACCINE
by: A. V. Rudakova, et al.
Published: (2019-03-01)

Economic renovation of a hillside drip irrigation system using drip tape inlet pressure regulators under computer-aided design
by: Xiaoran Wang, et al.
Published: (2025-02-01)

Similar overall survival with reduced vs. standard dose bevacizumab monotherapy in progressive glioblastoma
by: Jack Patrick Gleeson, et al.
Published: (2020-01-01)

Cost-effectiveness analysis of nirmatrelvir/ritonavir in adult patients at high risk of progressing to severe COVID-19
by: Carolina Moreno, et al.
Published: (2025-07-01)

Modeling long-term health and economic implications of new treatment strategies for Parkinson’s disease: an individual patient simulation study
by: Conor Chandler, et al.
Published: (2021-01-01)

Pharmacoeconomic analysis of fluid therapy in the treatment of patients with peritonitis
by: R. I. Yagudina, et al.
Published: (2015-03-01)